13 New 4-Star Stocks This Week
Morningstar identified 13 new 4-star undervalued stocks, including Marvell Technology (MRVL), Bristol-Myers Squibb (BMY), U.S. Bancorp (USB), Simon Property Group (SPG), and Devon Energy (DVN). The stocks are trading at discounts to their fair value estimates, with MRVL at 24%, BMY at 16%, USB at 12%, SPG at 13%, and DVN at 22%.
How this was made
The 30-second read
Why it matters
The upgrades provide a signal for value investors but lack a concrete catalyst beyond the rating change.
Market read
The article offers a modest trading signal for the five upgraded stocks, primarily for value‑focused strategies.
What to watch
Potential macro‑economic headwinds or sector‑specific risks could offset the perceived undervaluation.
Background
Morningstar’s weekly rating update highlights newly undervalued U.S. stocks based on price, fair‑value estimates, and uncertainty ratings.
Ticker impact
Morningstar upgraded Marvell Technology to a 4‑star rating, indicating it is now considered undervalued.
likely upward pressure as investors price in the new undervalued rating
The upgrade signals a valuation gap; no new catalyst beyond the rating change.
Morningstar upgraded Bristol‑Myers Squibb to a 4‑star rating, marking it as undervalued.
potential modest upside as the stock is now seen as cheaper than its fair value
Undervalued rating can prompt buying, but no immediate catalyst beyond the rating.
Morningstar upgraded U.S. Bancorp to a 4‑star rating, indicating it is undervalued.
likely modest upward pressure from value investors
The new rating highlights a discount to fair value, but no other news.
Morningstar upgraded Simon Property Group to a 4‑star rating, signaling undervaluation.
potential slight upside as the discount narrows
Undervalued rating is the sole new information.
Morningstar upgraded Devon Energy to a 4‑star rating, marking it as undervalued.
likely modest upward pressure given the discount to fair value
The rating change is the primary new data point.
Market effects
Value‑oriented investors may scan the listed stocks for entry points across tech, pharma, banking, REITs, and energy.
U.S. market focus; no broader regional effect.
Limited to investors tracking Morningstar ratings.
Counterpoint
Rating upgrades may be premature if underlying fundamentals do not support the fair‑value estimates.
Key entities
- Research FirmMorningstar
Provider of the rating methodology and source of the rating changes.
